null

SMILES: CN1CCN(CC1)C(=O)C1CC[C@@H](CC1)C(=O)Nc1cc2cc(ccc2cn1)-c1cnn(C)c1

InChI Key: InChIKey=LYTBFSXOMIMCTF-NZANSXMDSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 422359   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Proto-oncogene Wnt-1 (Homo sapiens (human))	BDBM422359 (US10508099, Compound 1091 | US10556885, Compound 1...) Show SMILES CN1CCN(CC1)C(=O)C1CC[C@@H](CC1)C(=O)Nc1cc2cc(ccc2cn1)-c1cnn(C)c1 |r,wU:12.16,(11.19,-1.15,;9.85,-.38,;8.52,-1.15,;7.19,-.38,;7.19,1.15,;8.52,1.93,;9.85,1.15,;5.85,1.93,;5.85,3.47,;4.52,1.15,;3.19,1.93,;1.85,1.15,;1.85,-.38,;3.19,-1.15,;4.52,-.38,;.52,-1.15,;.52,-2.69,;-.82,-.38,;-2.15,-1.15,;-3.48,-.38,;-4.82,-1.15,;-6.15,-.38,;-7.48,-1.15,;-7.48,-2.69,;-6.15,-3.47,;-4.82,-2.69,;-3.48,-3.47,;-2.15,-2.69,;-8.82,-.38,;-10.28,-.86,;-11.19,.38,;-10.28,1.63,;-11.05,2.96,;-8.82,1.15,)| Show InChI InChI=1S/C26H32N6O2/c1-30-9-11-32(12-10-30)26(34)19-5-3-18(4-6-19)25(33)29-24-14-22-13-20(7-8-21(22)15-27-24)23-16-28-31(2)17-23/h7-8,13-19H,3-6,9-12H2,1-2H3,(H,27,29,33)/t18-,19?	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2.95E+3	n/a	n/a	n/a	n/a
Samumed, LLC US Patent					Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh...				US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C
					More data for this Ligand-Target Pair
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human))	BDBM422359 (US10508099, Compound 1091 | US10556885, Compound 1...) Show SMILES CN1CCN(CC1)C(=O)C1CC[C@@H](CC1)C(=O)Nc1cc2cc(ccc2cn1)-c1cnn(C)c1 |r,wU:12.16,(11.19,-1.15,;9.85,-.38,;8.52,-1.15,;7.19,-.38,;7.19,1.15,;8.52,1.93,;9.85,1.15,;5.85,1.93,;5.85,3.47,;4.52,1.15,;3.19,1.93,;1.85,1.15,;1.85,-.38,;3.19,-1.15,;4.52,-.38,;.52,-1.15,;.52,-2.69,;-.82,-.38,;-2.15,-1.15,;-3.48,-.38,;-4.82,-1.15,;-6.15,-.38,;-7.48,-1.15,;-7.48,-2.69,;-6.15,-3.47,;-4.82,-2.69,;-3.48,-3.47,;-2.15,-2.69,;-8.82,-.38,;-10.28,-.86,;-11.19,.38,;-10.28,1.63,;-11.05,2.96,;-8.82,1.15,)| Show InChI InChI=1S/C26H32N6O2/c1-30-9-11-32(12-10-30)26(34)19-5-3-18(4-6-19)25(33)29-24-14-22-13-20(7-8-21(22)15-27-24)23-16-28-31(2)17-23/h7-8,13-19H,3-6,9-12H2,1-2H3,(H,27,29,33)/t18-,19?	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	1.40	n/a	n/a	n/a	n/a
Samumed, LLC US Patent					Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ...				US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C
					More data for this Ligand-Target Pair
Glycogen synthase kinase-3 beta (Homo sapiens (Human))	BDBM422359 (US10508099, Compound 1091 | US10556885, Compound 1...) Show SMILES CN1CCN(CC1)C(=O)C1CC[C@@H](CC1)C(=O)Nc1cc2cc(ccc2cn1)-c1cnn(C)c1 |r,wU:12.16,(11.19,-1.15,;9.85,-.38,;8.52,-1.15,;7.19,-.38,;7.19,1.15,;8.52,1.93,;9.85,1.15,;5.85,1.93,;5.85,3.47,;4.52,1.15,;3.19,1.93,;1.85,1.15,;1.85,-.38,;3.19,-1.15,;4.52,-.38,;.52,-1.15,;.52,-2.69,;-.82,-.38,;-2.15,-1.15,;-3.48,-.38,;-4.82,-1.15,;-6.15,-.38,;-7.48,-1.15,;-7.48,-2.69,;-6.15,-3.47,;-4.82,-2.69,;-3.48,-3.47,;-2.15,-2.69,;-8.82,-.38,;-10.28,-.86,;-11.19,.38,;-10.28,1.63,;-11.05,2.96,;-8.82,1.15,)| Show InChI InChI=1S/C26H32N6O2/c1-30-9-11-32(12-10-30)26(34)19-5-3-18(4-6-19)25(33)29-24-14-22-13-20(7-8-21(22)15-27-24)23-16-28-31(2)17-23/h7-8,13-19H,3-6,9-12H2,1-2H3,(H,27,29,33)/t18-,19?	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	69	n/a	n/a	n/a	n/a
Samumed, LLC US Patent					Assay Description GSK3B: This is a non-radioactive assay using fluorescence resonance energy transfer (FRET) between coumarin and fluorescein to detect kinase activity...				US Patent US10556885 (2020) BindingDB Entry DOI: 10.7270/Q2ZW1P9Z
					More data for this Ligand-Target Pair
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human))	BDBM422359 (US10508099, Compound 1091 | US10556885, Compound 1...) Show SMILES CN1CCN(CC1)C(=O)C1CC[C@@H](CC1)C(=O)Nc1cc2cc(ccc2cn1)-c1cnn(C)c1 |r,wU:12.16,(11.19,-1.15,;9.85,-.38,;8.52,-1.15,;7.19,-.38,;7.19,1.15,;8.52,1.93,;9.85,1.15,;5.85,1.93,;5.85,3.47,;4.52,1.15,;3.19,1.93,;1.85,1.15,;1.85,-.38,;3.19,-1.15,;4.52,-.38,;.52,-1.15,;.52,-2.69,;-.82,-.38,;-2.15,-1.15,;-3.48,-.38,;-4.82,-1.15,;-6.15,-.38,;-7.48,-1.15,;-7.48,-2.69,;-6.15,-3.47,;-4.82,-2.69,;-3.48,-3.47,;-2.15,-2.69,;-8.82,-.38,;-10.28,-.86,;-11.19,.38,;-10.28,1.63,;-11.05,2.96,;-8.82,1.15,)| Show InChI InChI=1S/C26H32N6O2/c1-30-9-11-32(12-10-30)26(34)19-5-3-18(4-6-19)25(33)29-24-14-22-13-20(7-8-21(22)15-27-24)23-16-28-31(2)17-23/h7-8,13-19H,3-6,9-12H2,1-2H3,(H,27,29,33)/t18-,19?	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	1.40	n/a	n/a	n/a	n/a
Samumed, LLC US Patent					Assay Description The DYRK1A kinase assay was run using the Ser/Thr 18 peptide Z-lyte assay kit according to manufacturer's instructions. This is a non-radioactive...				US Patent US10556885 (2020) BindingDB Entry DOI: 10.7270/Q2ZW1P9Z
					More data for this Ligand-Target Pair
Glycogen synthase kinase-3 beta (Homo sapiens (Human))	BDBM422359 (US10508099, Compound 1091 | US10556885, Compound 1...) Show SMILES CN1CCN(CC1)C(=O)C1CC[C@@H](CC1)C(=O)Nc1cc2cc(ccc2cn1)-c1cnn(C)c1 |r,wU:12.16,(11.19,-1.15,;9.85,-.38,;8.52,-1.15,;7.19,-.38,;7.19,1.15,;8.52,1.93,;9.85,1.15,;5.85,1.93,;5.85,3.47,;4.52,1.15,;3.19,1.93,;1.85,1.15,;1.85,-.38,;3.19,-1.15,;4.52,-.38,;.52,-1.15,;.52,-2.69,;-.82,-.38,;-2.15,-1.15,;-3.48,-.38,;-4.82,-1.15,;-6.15,-.38,;-7.48,-1.15,;-7.48,-2.69,;-6.15,-3.47,;-4.82,-2.69,;-3.48,-3.47,;-2.15,-2.69,;-8.82,-.38,;-10.28,-.86,;-11.19,.38,;-10.28,1.63,;-11.05,2.96,;-8.82,1.15,)| Show InChI InChI=1S/C26H32N6O2/c1-30-9-11-32(12-10-30)26(34)19-5-3-18(4-6-19)25(33)29-24-14-22-13-20(7-8-21(22)15-27-24)23-16-28-31(2)17-23/h7-8,13-19H,3-6,9-12H2,1-2H3,(H,27,29,33)/t18-,19?	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	69	n/a	n/a	n/a	n/a
Samumed, LLC US Patent					Assay Description Each compound is dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves f...				US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C
					More data for this Ligand-Target Pair